Ignite Creation Date:
2025-12-24 @ 7:30 PM
Ignite Modification Date:
2025-12-25 @ 5:11 PM
Study NCT ID:
NCT06132503
Status:
RECRUITING
Last Update Posted:
2025-03-17
First Post:
2023-11-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
Sponsor:
Lantern Pharma Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-03
Start Date Type:
ACTUAL
Primary Completion Date:
2028-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-03
First Submit QC Date:
None
Study First Post Date:
2023-11-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-12
Last Update Post Date:
2025-03-17
Last Update Post Date Type:
ACTUAL